Corum Group Ltd
ASX:COO
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Corum Group Ltd
ASX:COO
|
AU |
|
S
|
Shandong Weigao Blood Purification Products Co Ltd
SSE:603014
|
CN |
|
C
|
Chykingyoung Investment Development Holdings Inc
OTC:CHYI
|
CA |
|
Blusky AI Inc
OTC:BSAI
|
US |
|
Taitron Components Inc
NASDAQ:TAIT
|
US |
|
S
|
Sinco Pharmaceuticals Holdings Ltd
HKEX:6833
|
CN |
|
I
|
Incheon City Gas Co Ltd
KRX:034590
|
KR |
|
B
|
Bytetravel SA
MAD:SCBYT
|
ES |
Balance Sheet
Balance Sheet Decomposition
Corum Group Ltd
Corum Group Ltd
Balance Sheet
Corum Group Ltd
| Jun-2014 | Jun-2015 | Jun-2016 | Jun-2017 | Jun-2018 | Jun-2019 | Jun-2020 | Jun-2021 | Jun-2022 | Jun-2023 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||
| Cash & Cash Equivalents |
0
|
1
|
10
|
8
|
5
|
2
|
2
|
6
|
1
|
0
|
|
| Cash |
0
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
|
| Cash Equivalents |
0
|
0
|
10
|
8
|
5
|
2
|
2
|
6
|
0
|
0
|
|
| Short-Term Investments |
12
|
11
|
0
|
0
|
0
|
0
|
0
|
0
|
5
|
13
|
|
| Total Receivables |
4
|
3
|
1
|
2
|
3
|
4
|
6
|
2
|
3
|
3
|
|
| Accounts Receivables |
0
|
0
|
0
|
0
|
2
|
2
|
4
|
1
|
1
|
1
|
|
| Other Receivables |
4
|
2
|
0
|
1
|
2
|
2
|
2
|
2
|
2
|
2
|
|
| Inventory |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Assets |
0
|
0
|
2
|
2
|
3
|
3
|
2
|
1
|
0
|
7
|
|
| Total Current Assets |
16
|
15
|
13
|
12
|
11
|
9
|
10
|
10
|
9
|
23
|
|
| PP&E Net |
0
|
0
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
0
|
|
| PP&E Gross |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
|
| Accumulated Depreciation |
4
|
3
|
0
|
0
|
0
|
0
|
0
|
0
|
2
|
0
|
|
| Intangible Assets |
0
|
0
|
11
|
5
|
7
|
4
|
5
|
19
|
19
|
11
|
|
| Goodwill |
11
|
11
|
0
|
0
|
0
|
0
|
0
|
0
|
2
|
2
|
|
| Long-Term Investments |
0
|
0
|
0
|
0
|
0
|
0
|
3
|
0
|
0
|
0
|
|
| Other Long-Term Assets |
0
|
1
|
1
|
1
|
0
|
1
|
1
|
1
|
1
|
1
|
|
| Other Assets |
11
|
11
|
0
|
0
|
0
|
0
|
0
|
0
|
2
|
2
|
|
| Total Assets |
27
N/A
|
27
+0%
|
26
-4%
|
20
-24%
|
20
0%
|
15
-24%
|
19
+28%
|
31
+63%
|
31
-2%
|
37
+19%
|
|
| Liabilities | |||||||||||
| Accounts Payable |
2
|
3
|
5
|
4
|
4
|
4
|
4
|
5
|
3
|
1
|
|
| Accrued Liabilities |
0
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Liabilities |
5
|
3
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
11
|
|
| Total Current Liabilities |
8
|
7
|
6
|
6
|
5
|
5
|
5
|
6
|
5
|
12
|
|
| Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Deferred Income Tax |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
|
| Other Liabilities |
1
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
|
| Total Liabilities |
8
N/A
|
7
-13%
|
6
-16%
|
6
-6%
|
5
-5%
|
5
0%
|
6
+9%
|
8
+41%
|
8
-10%
|
14
+89%
|
|
| Equity | |||||||||||
| Common Stock |
86
|
86
|
86
|
86
|
86
|
86
|
90
|
98
|
98
|
98
|
|
| Retained Earnings |
67
|
66
|
66
|
72
|
72
|
77
|
77
|
75
|
75
|
76
|
|
| Total Equity |
19
N/A
|
20
+6%
|
20
0%
|
14
-30%
|
14
+2%
|
10
-33%
|
13
+38%
|
23
+74%
|
23
+1%
|
22
-4%
|
|
| Total Liabilities & Equity |
27
N/A
|
27
+0%
|
26
-4%
|
20
-24%
|
20
0%
|
15
-24%
|
19
+28%
|
31
+63%
|
31
-2%
|
37
+19%
|
|
| Shares Outstanding | |||||||||||
| Common Shares Outstanding |
254
|
255
|
270
|
270
|
270
|
270
|
425
|
597
|
597
|
597
|
|